Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, Chiba, Japan.
PLoS One. 2013 May 3;8(5):e63073. doi: 10.1371/journal.pone.0063073. Print 2013.
Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of action for the anti-inflammatory activity of MTX is not fully understood. METHODOLOGY/RESULT: Here, we performed a screening of MTX-binding proteins using T7 phage display with a synthetic biotinylated MTX derivative. We then characterized the interactions using surface plasmon resonance (SPR) analysis and electrophoretic mobility shift assay (EMSA). Using a T7 phage display screen, we identified T7 phages that displayed part of high-mobility group box 1 (HMGB1) protein (K86-V175). Binding affinities as well as likely binding sites were characterized using genetically engineered truncated versions of HMGB1 protein (Al G1-K87, Bj: F88-K181), indicating that MTX binds to HMGB1 via two independent sites with a dissociation constants (KD) of 0.50±0.03 µM for Al and 0.24 ± 0.01 µM for Bj. Although MTX did not inhibit the binding of HMGB1 to DNA via these domains, HMGB1/RAGE association was impeded in the presence of MTX. These data suggested that binding of MTX to part of the RAGE-binding region (K149-V175) in HMGB1 might be significant for the anti-inflammatory effect of MTX. Indeed, in murine macrophage-like cells (RAW 264.7), TNF-α release and mitogenic activity elicited by specific RAGE stimulation with a truncated monomeric HMGB1 were inhibited in the presence of MTX.
CONCLUSIONS/SIGNIFICANCE: These data demonstrate that HMGB1 is a direct binding protein of MTX. Moreover, binding of MTX to RAGE-binding region in HMGB1 inhibited the HMGB1/RAGE interaction at the molecular and cellular levels. These data might explain the molecular basis underlying the mechanism of action for the anti-inflammatory effect of MTX.
甲氨蝶呤(MTX)是一种用于肿瘤和自身免疫性疾病(包括类风湿关节炎(RA))化疗的药物。此外,MTX 具有一定的抗炎活性。虽然二氢叶酸还原酶(DHFR)是 MTX 抗肿瘤作用的一个众所周知的靶点,但 MTX 抗炎活性的作用模式尚未完全阐明。
方法/结果:在这里,我们使用带有合成生物素化 MTX 衍生物的 T7 噬菌体展示进行了 MTX 结合蛋白的筛选。然后,我们使用表面等离子体共振(SPR)分析和电泳迁移率变动分析(EMSA)来表征相互作用。使用 T7 噬菌体展示筛选,我们鉴定出展示高迁移率族框 1(HMGB1)蛋白部分(K86-V175)的 T7 噬菌体。使用 HMGB1 蛋白的基因工程截断版本(Al G1-K87,Bj:F88-K181),我们对结合亲和力和可能的结合位点进行了表征,表明 MTX 通过两个独立的位点与 HMGB1 结合,解离常数(KD)为 0.50±0.03 μM 对于 Al 和 0.24 ± 0.01 μM 对于 Bj。尽管 MTX 没有抑制这些结构域中 HMGB1 与 DNA 的结合,但在 MTX 存在下,HMGB1/RAGE 结合受到阻碍。这些数据表明,MTX 与 HMGB1 的 RAGE 结合区域(K149-V175)的部分结合可能对 MTX 的抗炎作用具有重要意义。事实上,在鼠巨噬细胞样细胞(RAW 264.7)中,在用截断的单体 HMGB1 特异性刺激 RAGE 时,TNF-α 释放和有丝分裂活性在 MTX 存在下受到抑制。
结论/意义:这些数据表明 HMGB1 是 MTX 的直接结合蛋白。此外,MTX 与 HMGB1 的 RAGE 结合区域的结合抑制了分子和细胞水平上的 HMGB1/RAGE 相互作用。这些数据可能解释了 MTX 抗炎作用的作用机制的分子基础。